White House doubles down on call to fund FDA entirely with industry fees
WASHINGTON, DC — Following the House of Representatives’ passage of the bill to reauthorize FDA user fees on Wednesday, the White House doubled down on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.